Preclinical toxicological evaluation of fostriecin, a novel anticancer antibiotic, in rats.
about
Suppression of Ser/Thr phosphatase 4 (PP4C/PPP4C) mimics a novel post-mitotic action of fostriecin, producing mitotic slippage followed by tetraploid cell deathPhase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin.Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and( beta12-beta13)-chimeras (PP1/PP2A and PP5/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitors
P2860
Preclinical toxicological evaluation of fostriecin, a novel anticancer antibiotic, in rats.
description
1990 nî lūn-bûn
@nan
1990 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Preclinical toxicological eval ...... nticancer antibiotic, in rats.
@ast
Preclinical toxicological eval ...... nticancer antibiotic, in rats.
@en
type
label
Preclinical toxicological eval ...... nticancer antibiotic, in rats.
@ast
Preclinical toxicological eval ...... nticancer antibiotic, in rats.
@en
prefLabel
Preclinical toxicological eval ...... nticancer antibiotic, in rats.
@ast
Preclinical toxicological eval ...... nticancer antibiotic, in rats.
@en
P2093
P1476
Preclinical toxicological eval ...... nticancer antibiotic, in rats.
@en
P2093
P304
P356
10.1016/0272-0590(90)90053-M
P577
1990-08-01T00:00:00Z